A Phase III, Multicentre, Double-blind, Prospective, Randomized, Placebo-controlled Study, Assessing the Efficacy and Safety of Dysport® Used for the Treatment of Lower-limb Spasticity in Adult Subjects With Hemiparesis Due to Stroke or Traumatic Brain Injury

Ipsen

Description

The purpose of this research study is to assess the efficacy of Dysport® compared to placebo in improving muscle tone in hemiparetic subjects with lower limb spasticity due to stroke or traumatic brain injury.

Citations (0)

No citations found

It looks like this dataset has no citations.

Mentions (0)

No mentions found

It looks like this dataset has not been mentioned in any sources.

Metrics

Dataset Index

0.7

FAIR Score

31%

Citations

Mentions

Metrics Over Time

Publication Details

DOI

10.25934/pr00008366

Publisher

Vivli

Assigned Domain

Subfield

Epidemiology

Field

Medicine

Domain

Health Sciences

Confidence Score

52%

Source

Scholar Data Model

Keywords

Conditions: Leg SpasticityInterventions: Botulinum toxin type AInterventions: Placebo

Normalization Factors

15.38

CTw

1.00

MTw

1.00